July 3, 2024
Investors

Class action lawsuit filed on behalf

Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, June 29, 2024 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Biogen Inc. (“Biogen”) (NASDAQ: BIIB) investors who suffered substantial losses to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883

Read More
Investors

Biogen Inc. (Nasdaq: BIIB) Investors Notice: Class action

Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, May 29, 2024 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Biogen Inc. (Nasdaq: BIIB) (“Biogen” or the “Company”) investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise

Read More
Investors

Robbins LLP Informs Investors that a

SAN DIEGO, May 24, 2024 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. (NASDAQ: BIIB) securities between February 3, 2022 and February 13, 2024. Biogen is a global biopharmaceutical company that discovers, develops, and delivers therapies for

Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline